MedTrace Logo

Use Of Valproid Acid To Treat Tropical Spastic Paraparesis/HTLV-1-Associated Myelopathy (TSP/HAM)

NCT00681980 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2015-12-03

No results posted yet for this study

Summary

Is the valproic acid efficacy to treat TSP/HAM

Conditions

  • Paraparesis Spastic Tropical

Interventions

DRUG

Valproic acid

15 mg/kg/day

DRUG

costicosteroids

metypredsolone 1 g/day

DRUG

valproid acid plus corticosteroids

valporid acid 15 mg/kg/day plus corticosteroids 1 g/patient

Sponsors & Collaborators

  • University of Sao Paulo

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-02-29
Primary Completion
2009-09-30
Completion
2015-12-31

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00681980 on ClinicalTrials.gov